J&J reports 11.9 pct fall in quarterly profit

FAN Editor

Oct 17 (Reuters) – Johnson & Johnson, which completed its $30 billion acquisition of Swiss biotech Actelion in June, reported a 11.9 percent fall in quarterly profit as costs rose.

Continue Reading Below

The company’s net earnings fell to $3.76 billion, or $1.37 per share, in the third quarter from $4.27 billion, or $1.53 per share, a year earlier.

More from FOX Business

However, the diversified healthcare company’s sales rose 10.3 percent to $19.65 billion in the quarter.

(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Anil D’Silva)

Leave a Reply

Next Post

Bad news for the bulls: There are now more bulls

The Investors Intelligence Bull/Bear ratio has climbed back above 4 for the first time since April 2015 — which ironically may serve as a bad sign for the market. “It does make me nervous, because we’re getting very, very frothy on these social indicators,” trader and strategist Boris Schlossberg of […]

You May Like